Onxeo S.A. buy Biotechhunter
Start price
25.06.20
/
50%
€0.79
Target price
31.07.20
-
Performance (%)
-16.05%
End price
31.07.20
€0.66
Summary
This prediction ended on 31.07.20 with a price of €0.66. The prediction for Onxeo S.A. disappointed with a performance of -16.05%. Biotechhunter has 50% into this predictionOnxeo is a cutting-edge biotechnology company that specializes in the research and development of novel drugs to treat patients with rare or resistant cancers. Headquartered in Paris, France, this innovative firm has established itself as a leader in the field by leveraging its advanced platform, known as DNA Therapeutics, in conjunction with a comprehensive portfolio of small molecules and orphan oncology assets. With a strong commitment to scientific excellence and a robust intellectual property strategy, Onxeo aims to improve patient outcomes by addressing critical unmet medical needs and creating value for stakeholders through strategic partnerships and licensing deals.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onxeo S.A. | -1.706% | -1.706% | -60.138% | -83.660% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
Comments by Biotechhunter for this prediction
In the thread Onxeo S.A. diskutieren
Buy Onxeo S.A.